Sd

Stephanie de Marco

Investor at Angels Santé

France

Overview

Work Experience

  • Chief Executive Officer

    2021 - Current

  • Chief Business Officer

    2019 - 2021

    After 15 years developing new businesses for big corps and 6 years investing in innovative startups, I have decided to combine both. I have invested in Sentinhealth and will work hard to fund and bring to the market an AI-powered device that will hopefully move heart failure patients from emergency care to homecare.

  • Startup Investor & Board Member

    2013

    Personal investments in 15 healthcare startups

  • President

    2013 - 2019

    Building the 1st private investor network dedicated to Healthcare in Europe. (100+ investors - 55 deals) Activity : Early-stage investment & business support for fast-growing companies. Scope : rounds of 500K-2.5 Mo€ in Biotech - Medtech - Diagnostics - Digital Health

  • Key Account Manager (hospitals & local payors - all divisions)

    2012 - 2012

    Kick-off of Abbott Pharmaceuticals multi-stakeholder strategy in the field

  • Sales Manager (primary care products)

    2009 - 2011

    Local execution of the European strategy: supporting sales & team transition in the French affiliate before restructuring

  • Commercial Director (primary care & hospital neonat)

    2008 - 2009

    Head of commercial strategy & operations in Primary Care & Immuno-Neonat (500+ people - $850Mo sales) Primary Care : Product life-cycle management and transition from Rx to OTC business and Restructuring plan in affiliates where OTC is not an option. Hospital Neonatology (immunotherapy): building a cross-functional business team to design & implement a new way-to-market in affiliates. Develop multi-stakeholder strategies directed to prescribers, distributors, patients, payors, politicians.

  • Marketing Manager (all divisions)

    2007 - 2007

    Transition of 3M Pharma business to Meda

  • Franchise Manager (immunology)

    2005 - 2006

    Sales & Marketing Strategy in Europe. New product development with the global team.

  • Product Manager (dermatology/gynaecology)

    2004 - 2005

    Launch of 1st in-class immunostimulator in skin cancer & HPV across 27 countries.

  • Patient Communication Manager (all divisions)

    2003 - 2003

    Launch of 1st patient campaign against HPV across Europe.

  • Strategic Business Analyst (all divisions)

    2001 - 2002

    (3M corporate leadership program) Identification of new business opportunities for 3M Europe Board of Directors resulting in business unit openings and one global acquisition ($>1Bo). Consumer - Industrial - Healthcare Markets.

  • Junior Product Manager (consumer)

    1999 - 2001

    Launch of baby product range with KOLs in dermatology

Relevant Websites